Synthaverse S.A. (SVE.WA)
PLN 4.7
(2.85%)
PLN 4.7
(2.85%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 15.48 Million PLN | 22.15% |
| 2022 | 12.67 Million PLN | 35.94% |
| 2021 | 9.32 Million PLN | 2.48% |
| 2020 | 9.09 Million PLN | 5.47% |
| 2019 | 8.62 Million PLN | 24.33% |
| 2018 | 6.93 Million PLN | -25.54% |
| 2017 | 9.31 Million PLN | -13.1% |
| 2016 | 10.72 Million PLN | -69.14% |
| 2015 | 34.74 Million PLN | -25.12% |
| 2014 | 46.4 Million PLN | 5.88% |
| 2013 | 43.82 Million PLN | 5.7% |
| 2012 | 41.46 Million PLN | 82.04% |
| 2011 | 22.77 Million PLN | 94.73% |
| 2010 | 11.69 Million PLN | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 14.39 Million PLN | -7.01% |
| 2024 Q2 | 14.19 Million PLN | -1.44% |
| 2023 Q2 | 13.35 Million PLN | -6.85% |
| 2023 Q4 | 15.48 Million PLN | -5.2% |
| 2023 FY | 15.48 Million PLN | 22.15% |
| 2023 Q3 | 16.33 Million PLN | 22.29% |
| 2023 Q1 | 14.33 Million PLN | 13.11% |
| 2022 Q3 | 11.53 Million PLN | 2.99% |
| 2022 FY | 12.67 Million PLN | 35.94% |
| 2022 Q2 | 11.2 Million PLN | 10.59% |
| 2022 Q4 | 12.67 Million PLN | 9.87% |
| 2022 Q1 | 10.12 Million PLN | 8.62% |
| 2021 Q3 | 10.32 Million PLN | 0.0% |
| 2021 Q4 | 9.32 Million PLN | -9.68% |
| 2021 FY | 9.32 Million PLN | 2.48% |
| 2021 Q1 | 10.88 Million PLN | 19.62% |
| 2020 Q2 | 8.45 Million PLN | 1.2% |
| 2020 Q4 | 9.09 Million PLN | -2.52% |
| 2020 FY | 9.09 Million PLN | 5.47% |
| 2020 Q3 | 9.33 Million PLN | 10.46% |
| 2020 Q1 | 8.35 Million PLN | -3.21% |
| 2019 Q3 | 9.64 Million PLN | 20.5% |
| 2019 Q4 | 8.62 Million PLN | -10.52% |
| 2019 Q2 | 8 Million PLN | 21.17% |
| 2019 Q1 | 6.6 Million PLN | -4.84% |
| 2019 FY | 8.62 Million PLN | 24.33% |
| 2018 Q3 | 10.2 Million PLN | -4.36% |
| 2018 Q1 | 9.35 Million PLN | 0.33% |
| 2018 Q4 | 6.93 Million PLN | -31.99% |
| 2018 FY | 6.93 Million PLN | -25.54% |
| 2018 Q2 | 10.66 Million PLN | 14.1% |
| 2017 Q4 | 9.31 Million PLN | 27.48% |
| 2017 FY | 9.31 Million PLN | -13.1% |
| 2017 Q2 | 7.89 Million PLN | 0.87% |
| 2017 Q3 | 7.31 Million PLN | -7.37% |
| 2017 Q1 | 7.82 Million PLN | -27.04% |
| 2016 Q4 | 10.72 Million PLN | -51.23% |
| 2016 FY | 10.72 Million PLN | -69.14% |
| 2016 Q2 | 25.44 Million PLN | -24.34% |
| 2016 Q3 | 21.98 Million PLN | -13.58% |
| 2016 Q1 | 33.62 Million PLN | -3.23% |
| 2015 Q4 | 34.74 Million PLN | -38.21% |
| 2015 FY | 34.74 Million PLN | -25.12% |
| 2015 Q3 | 56.23 Million PLN | 0.57% |
| 2015 Q2 | 55.92 Million PLN | 0.11% |
| 2015 Q1 | 55.85 Million PLN | 20.37% |
| 2014 FY | 46.4 Million PLN | 5.88% |
| 2014 Q1 | 44.66 Million PLN | 1.91% |
| 2014 Q2 | 46.9 Million PLN | 5.02% |
| 2014 Q4 | 46.4 Million PLN | -2.33% |
| 2014 Q3 | 47.51 Million PLN | 1.29% |
| 2013 Q3 | 43.54 Million PLN | 2.69% |
| 2013 Q4 | 43.82 Million PLN | 0.66% |
| 2013 Q2 | 42.4 Million PLN | 0.12% |
| 2013 Q1 | 42.35 Million PLN | 2.13% |
| 2013 FY | 43.82 Million PLN | 5.7% |
| 2012 Q4 | 41.46 Million PLN | 0.0% |
| 2012 FY | 41.46 Million PLN | 82.04% |
| 2011 FY | 22.77 Million PLN | 94.73% |
| 2010 FY | 11.69 Million PLN | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Bioceltix S.A. | 8617.89 PLN | -179572.751% |
| BIOTON S.A. | 117.91 Million PLN | 86.869% |
| Captor Therapeutics Spolka Akcyjna | - PLN | -Infinity% |
| Mabion S.A. | 6.84 Million PLN | -126.275% |
| Molecure S.A. | - PLN | -Infinity% |
| NanoGroup S.A. | 63.37 Thousand PLN | -24331.191% |
| Pharmena S.A. | 445 Thousand PLN | -3379.551% |
| Poltreg S.A. | 415 Thousand PLN | -3631.084% |
| Pure Biologics Spólka Akcyjna | 17.56 Million PLN | 11.857% |
| Ryvu Therapeutics S.A. | 2.11 Million PLN | -631.067% |
| Urteste S.A. | 162 Thousand PLN | -9458.025% |